Brenda Libby Coleman

Array ( [id] => 5539755 [patent_doc_number] => 20090221560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Pharmaceutical Formulation' [patent_app_type] => utility [patent_app_number] => 12/092033 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2241 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221560.pdf [firstpage_image] =>[orig_patent_app_number] => 12092033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545159 [patent_doc_number] => 20100016289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Compounds Useful as Antagonists of CCR2' [patent_app_type] => utility [patent_app_number] => 12/084357 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28240 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016289.pdf [firstpage_image] =>[orig_patent_app_number] => 12084357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546925 [patent_doc_number] => 20090156802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Quetiapine Hemifumarate Purification by Crystallization' [patent_app_type] => utility [patent_app_number] => 12/083975 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2055 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156802.pdf [firstpage_image] =>[orig_patent_app_number] => 12083975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343292 [patent_doc_number] => 20090181942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'TRICYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/090870 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 471928 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181942.pdf [firstpage_image] =>[orig_patent_app_number] => 12090870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057652 [patent_doc_number] => 20070060574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/551188 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7707 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060574.pdf [firstpage_image] =>[orig_patent_app_number] => 11551188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983463 [patent_doc_number] => 20070088022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Tetrahydroquinolines, synthesis thereof, and intermediates thereto' [patent_app_type] => utility [patent_app_number] => 11/581638 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12720 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20070088022.pdf [firstpage_image] =>[orig_patent_app_number] => 11581638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194406 [patent_doc_number] => 20070082890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/542944 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66162 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082890.pdf [firstpage_image] =>[orig_patent_app_number] => 11542944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265812 [patent_doc_number] => 20090118497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => ' Crystallization Process of Quetiapine Hemifumarate' [patent_app_type] => utility [patent_app_number] => 11/992223 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2492 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118497.pdf [firstpage_image] =>[orig_patent_app_number] => 11992223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485984 [patent_doc_number] => 20090275749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'PRODUCTION METHOD OF OPTICALLY ACTIVE PIPERAZINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/067677 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14367 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275749.pdf [firstpage_image] =>[orig_patent_app_number] => 12067677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172624 [patent_doc_number] => 20070073057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Method for preparation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide' [patent_app_type] => utility [patent_app_number] => 11/525811 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5128 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20070073057.pdf [firstpage_image] =>[orig_patent_app_number] => 11525811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070241 [patent_doc_number] => 20070191343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => '4-((4-(2-Azaperhydroepinylethoxy)phenyl)methyl)-3-2(2,4-dichlorophenyl)-7-hydroxychromen-2-one, pharmaceutically acceptable salts thereof and methods of use therewith' [patent_app_type] => utility [patent_app_number] => 11/523376 [patent_app_country] => US [patent_app_date] => 2006-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11640 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191343.pdf [firstpage_image] =>[orig_patent_app_number] => 11523376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142491 [patent_doc_number] => 20070004707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => '[1,4]Diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents' [patent_app_type] => utility [patent_app_number] => 11/518216 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19387 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004707.pdf [firstpage_image] =>[orig_patent_app_number] => 11518216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373385 [patent_doc_number] => 07473688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 11/516435 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82857 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473688.pdf [firstpage_image] =>[orig_patent_app_number] => 11516435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5559035 [patent_doc_number] => 20090270612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Therapeutic Agent for Osteoporosis Using a Retinoid X Receptor-Related Compound' [patent_app_type] => utility [patent_app_number] => 12/065994 [patent_app_country] => US [patent_app_date] => 2006-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3847 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270612.pdf [firstpage_image] =>[orig_patent_app_number] => 12065994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860346 [patent_doc_number] => 20080269196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => '6-Arylalkylamino-2,3,4,5-Tetrahydro-1H-Benzo[D]Azepines as 5-Ht2c Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/996751 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74482 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269196.pdf [firstpage_image] =>[orig_patent_app_number] => 11996751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664185 [patent_doc_number] => 20080255092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => '6-Substituted-2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/996457 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41971 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255092.pdf [firstpage_image] =>[orig_patent_app_number] => 11996457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760110 [patent_doc_number] => 08420631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => '6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/995344 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29512 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11995344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596103 [patent_doc_number] => 07981882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => '6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/995212 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22677 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981882.pdf [firstpage_image] =>[orig_patent_app_number] => 11995212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485982 [patent_doc_number] => 20090275747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'METHODS FOR THE PREPARATION OF SALTS OF 2-[2-(4-DIBENZO[B,F][1,4]THIAZEPIN-11-YL-1-PIPERAZINYL)ETHOXYL]ETHANOL (QUETIAPINE) AND FOR THE PURIFICATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/306691 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2560 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275747.pdf [firstpage_image] =>[orig_patent_app_number] => 12306691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 260061 [patent_doc_number] => 07572787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-11 [patent_title] => 'Substituted naphthalene sulfonamides' [patent_app_type] => utility [patent_app_number] => 11/510324 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34230 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/572/07572787.pdf [firstpage_image] =>[orig_patent_app_number] => 11510324 [rel_patent_id] =>[rel_patent_doc_number] =>)